Int J Drug Res Clin. 2023;1: e19 | Published on: 2023 Nov 29. doi: 10.34172/ijdrc.2023.e19

Review Article

Incretin-Based Therapies and the Risk of Breast Cancer in Women with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Mobina Oladghaffari ¹ * , Sama Rahnemayan ² , Zahra Tohid ¹ , Majid Montazer ³ , Farnaz Dabiri ⁴

Cited by CrossRef: 1

1- Yonatan E, Jusni L, Alvianto S, Widjanarko N, Usman S, Muzellina V. Do Incretin-Based Therapies Influence the Risk of Cholangiocarcinoma in Type 2 Diabetes Patients? Insights from a Systematic Review and Meta-Analysis. J Gastrointest Canc. 2025;56(1) [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Aims and Scope Editorial Policies Contact Us Indexing and Abstracting Messages Announcements Archive

Platinum* Open Access

*This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website.